This website is intended for healthcare professionals only

APAC Consensus Recommendation on XLH – Multidisciplinary Management (Prof Craig F. Munns)

Part 2 - Clinical Evidence of Burosumab & Other Clinical evidence

More Videos

APAC Consensus Recommendation on XLH – Screening and Diagnosis (Prof Manju Chandran)

Full Video

APAC Consensus Recommendation on XLH – Transition of Care (Prof Rhee Yumie)

Website developed and funded by Kyowa Kirin Asia Pacific Pte. Ltd. © 2024 Kyowa Kirin Asia Pacific Pte. Ltd. SG-CRV-22-00006 AUG2024

logo-crysvita

This website is for healthcare professionals only, please login below or

Welcome to Crysvita.Asia website!

Crysvita.Asia website is a branded website to deepen the understanding of healthcare professionals on the treatment and management of X-Linked Hypophosphatemia (XLH) and Crysvita® (Burosumab).

It showcases results from clinical trials and treatment management, as well as useful information, resources, links and contact information.

Login below or create an account to get all the latest updates on XLH and Crysvita (Burosumab) from this website:

logo_header_01
logo-crysvita
logo-crysvita.png
logo-crysvita.png
logo-crysvita.png
logo-crysvita.png
logo-crysvita-1.png
You will be accessing an external site. Click “OK” to continue.